NCT00004243View on ClinicalTrials.gov

Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor

PHASE1CompletedINTERVENTIONAL
Timeline

Start Date

March 31, 2000

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

docetaxel

DRUG

oxaliplatin

Trial Locations (3)

91010

Beckman Research Institute, City of Hope, Los Angeles

95817

University of California Davis Cancer Center, Sacramento

90033-0800

USC/Norris Comprehensive Cancer Center, Los Angeles

All Listed Sponsors
lead

City of Hope Medical Center

OTHER

collaborator

National Cancer Institute (NCI)

NIH

NCT00004243 - Docetaxel and Oxaliplatin in Treating Patients With Metastatic or Recurrent Solid Tumor | Biotech Hunter | Biotech Hunter